Cargando…
P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430965/ http://dx.doi.org/10.1097/01.HS9.0000970424.05174.3c |
| _version_ | 1785091086164688896 |
|---|---|
| author | Leleu, Xavier Raje, Noopur Lesokhin, Alexander Mohty, Mohamad Nooka, Ajay Leip, Eric Sullivan, Sharon T. Viqueira, Andrea Manier, Salomon |
| author_facet | Leleu, Xavier Raje, Noopur Lesokhin, Alexander Mohty, Mohamad Nooka, Ajay Leip, Eric Sullivan, Sharon T. Viqueira, Andrea Manier, Salomon |
| author_sort | Leleu, Xavier |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430965 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309652023-08-17 P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3 Leleu, Xavier Raje, Noopur Lesokhin, Alexander Mohty, Mohamad Nooka, Ajay Leip, Eric Sullivan, Sharon T. Viqueira, Andrea Manier, Salomon Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430965/ http://dx.doi.org/10.1097/01.HS9.0000970424.05174.3c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Leleu, Xavier Raje, Noopur Lesokhin, Alexander Mohty, Mohamad Nooka, Ajay Leip, Eric Sullivan, Sharon T. Viqueira, Andrea Manier, Salomon P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title | P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_full | P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_fullStr | P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_full_unstemmed | P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_short | P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3 |
| title_sort | p880: efficacy and safety of elranatamab by age and frailty in patients with relapsed/refractory multiple myeloma (rrmm): a subgroup analysis from magnetismm-3 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430965/ http://dx.doi.org/10.1097/01.HS9.0000970424.05174.3c |
| work_keys_str_mv | AT leleuxavier p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT rajenoopur p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT lesokhinalexander p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT mohtymohamad p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT nookaajay p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT leiperic p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT sullivansharont p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT viqueiraandrea p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 AT maniersalomon p880efficacyandsafetyofelranatamabbyageandfrailtyinpatientswithrelapsedrefractorymultiplemyelomarrmmasubgroupanalysisfrommagnetismm3 |